CGRP as a new target in prevention and treatment of migraine

Lancet Neurol. 2014 Nov;13(11):1065-1067. doi: 10.1016/S1474-4422(14)70228-5. Epub 2014 Oct 5.

Author

Hans-Christoph Diener¹

Affiliation

¹ Department of Neurology and Headache Center, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany. Electronic address: hans.diener@uk-essen.de.

PMID: 25297015
DOI: 10.1016/S1474-4422(14)70228-5

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal / administration & dosage*
Antibodies, Monoclonal / adverse effects*
Calcitonin Gene-Related Peptide / antagonists & inhibitors*
Female
Humans
Male
Migraine Disorders / diagnosis*
Migraine Disorders / prevention & control*

Substances

Antibodies, Monoclonal
Calcitonin Gene-Related Peptide